Select An Article
Leal Therapeutics Inks $30 Million Series A Extension
2026-08-17
WORCESTER, MA, Leal Therapeutics, Inc. (Leal), a clinical-stage biopharmaceutical company, announced a second close of $30 million of its Series A financing.
Read More
Read More
Xpander Raises $7.5M Seed
2026-08-17
SAN FRANCISCO, CA, Xpander announced a $7.5 million Seed round led by Pico Venture Partners.
Read More
Read More
